Comments
India's Piramal Healthcare to buy U.S. firm to boost R&D
16.05.2012. | MUMBAI (Reuters) - Indian drugmaker Piramal Healthcare has agreed to buy a U.S.-based healthcare data provider for $635 million to boost research and development, the company said on Wednesday, a month after it acquired the new molecules division of Germany's Bayer's....
